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Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels and the Ih current they generate contribute to the pathophysiolog-
ical mechanisms of absence seizures (ASs), but their precise role in neocortical and thalamic neuronal populations, the main components
of the network underlying AS generation, remains controversial. In diverse genetic AS models, Ih amplitude is smaller in neocortical
neurons and either larger or unchanged in thalamocortical (TC) neurons compared with nonepileptic strains. A lower expression of
neocortical HCN subtype 1 channels is present in genetic AS-prone rats, and HCN subtype 2 knock-out mice exhibit ASs. Furthermore,
whereas many studies have characterized Ih contribution to “absence-like” paroxysmal activity in vitro, no data are available on the
specific role of cortical and thalamic HCN channels in behavioral seizures. Here, we show that the pharmacological block of HCN channels
with the antagonist ZD7288 applied via reverse microdialysis in the ventrobasal thalamus (VB) of freely moving male Genetic Absence
Epilepsy Rats from Strasbourg decreases TC neuron firing and abolishes spontaneous ASs. A similar effect is observed on
-hydroxybutyric acid-elicited ASs in normal male Wistar rats. Moreover, thalamic knockdown of HCN channels via virally delivered
shRNA into the VB of male Stargazer mice, another genetic AS model, decreases spontaneous ASs and Ih-dependent electrophysiological
properties of VB TC neurons. These findings provide the first evidence that block of TC neuron HCN channels prevents ASs and suggest
that any potential anti-absence therapy that targets HCN channels should carefully consider the opposite role for cortical and thalamic Ih
in the modulation of absence seizures.
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Significance Statement
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels play critical roles in the fine-tuning of cellular and network
excitability and have been suggested to be a key element of the pathophysiological mechanism underlying absence seizures.
However, the precise contribution of HCN channels in neocortical and thalamic neuronal populations to these nonconvulsive
seizures is still controversial. In the present study, pharmacological block and genetic suppression of HCN channels in thalamo-
cortical neurons in the ventrobasal thalamic nucleus leads to a marked reduction in absence seizures in one pharmacological and
two genetic rodent models of absence seizures. These results provide the first evidence that block of TC neuron HCN channels
prevents absence seizures.
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Introduction
Absence seizures (ASs), which consist of relatively brief periods of
lack of consciousness accompanied by spike-and-wave discharges
(SWDs) in the EEG, are a feature of many genetic generalized epi-
lepsies and believed to be generated by abnormal neuronal activity in
reciprocally connected neocortical and thalamic territories (Crunelli
and Leresche, 2002; Blumenfeld, 2005). Among the different
voltage-dependent channels that may be involved in the pathophys-
iological mechanisms of these nonconvulsive seizures, hyper-
polarization-activated cyclic nucleotide-gated (HCN) channels,
which are present in the vast majority of cortical and thalamic
neurons, have been extensively investigated (Huang et al., 2009;
Noam et al., 2011; Reid et al., 2012). However, the selective con-
tribution of cortical versus thalamic HCN channels in ASs is still
not fully understood (Noam et al., 2011).
Several studies in humans have reported an association be-
tween HCN channel mutations and genetic epilepsies: in partic-
ular, mutations in HCN subtype 1 (HCN1) and HCN subtype 2
(HCN2) were reported in patients with genetic generalized epi-
lepsies (Tang et al., 2008; DiFrancesco et al., 2011), including
febrile seizures and early infantile epileptic encephalopathy (Na-
kamura et al., 2013; Nava et al., 2014). However, it is difficult to
draw any firm conclusion from these human studies since ASs are
not the only phenotype present in these diverse forms of epilepsy.
As far as cellular effects are concerned, in vitro studies have
shown that blocking the Ih current that HCN channels generate
in thalamocortical (TC) neurons enhances bicuculline-elicited
synchronized thalamic activity resembling absence paroxysms by
increasing burst firing in TC neurons (Bal and McCormick, 1996).
The observation that mice with spontaneous or induced genetic
ablation of HCN2 channels exhibit ASs (Ludwig et al., 2003;
Chung et al., 2009; Heuermann et al., 2016) has been interpreted
as providing support to this view. However, since HCN2 chan-
nels are highly expressed in both cortical and thalamic neurons
(Notomi and Shigemoto, 2004), these in vivo data cannot be used
to draw any firm conclusion on a pro-absence role of thalamic HCN
channels. Indeed, in genetic AS models, Ih of neocortical neurons is
smaller (Strauss et al., 2004; Kole et al., 2007), resulting in increased
temporal summation of EPSPs and enhanced burst firing (Strauss et
al., 2004), whereas in TC neurons, Ih has been reported to be either
larger or unchanged compared with nonepileptic strains (Kuisle et
al., 2006; Kanyshkova et al., 2012; Cain et al., 2015) and the ability of
burst firing is decreased (Cain et al., 2015). More importantly, the
precise influence of HCN channels of thalamic versus cortical neu-
rons on behavioral seizures has never been investigated. This, to-
gether with the complexity of the diverse cellular and synaptic effects
that Ih can exert under normal conditions and their consequences on
paroxysmal network excitability (Huang et al., 2009; Noam et al.,
2011; Reid et al., 2012), makes it difficult to draw causal links be-
tween HCN channel function and ASs.
Here, we directly investigated the role of thalamic HCN chan-
nels in ASs using both pharmacological and genetic tools to
selectively suppress HCN channel function in TC neurons in
rodent models of absence epilepsy under freely moving condi-
tions. We report that bilateral reverse microdialysis application of
the HCN blocker ZD7288 into the ventrobasal thalamus (VB)
blocks ASs in two well established absence models, the Genetic
Absence Epilepsy Rats from Strasbourg (GAERS; Depaulis et al.,
2015) and the -hydroxybutyric acid (GHB)-injected Wistar rats
(Venzi et al., 2015), and decreases tonic, but not burst, firing in
TC neurons of freely moving GAERS. Furthermore, silencing
thalamic HCN gene expression with shRNA in the VB nucleus of
Stargazer mice, another genetic absence epilepsy model (Fletcher
and Frankel, 1999), is effective in reducing spontaneous ASs. Thus,
in contrast to inferences from previous in vitro studies in thalamic
slices (Kuisle et al., 2006; Kanyshkova et al., 2012) and in vivo
investigations using brain-wide HCN channel manipulations
(Ludwig et al., 2003; Chung et al., 2009), block of TC neuron
HCN channels prevents ASs.
Materials and Methods
All experimental procedures were performed in accordance with the UK
Animals (Scientific Procedures) Act 1986 and local ethics committee and
expert group guidelines (Lidster et al., 2015). All efforts were made to
minimize animal suffering and the number of animals used. Experiments
were performed on adult (2–5 months old) male Wistar (Harlan Labo-
ratories) and GAERS (School of Bioscience, Cardiff University) rats and
Stargazer mice (School of Bioscience, Cardiff University), which were
maintained on a normal diet and under an 8.00 A.M. to 8.00 P.M. light-
on/light-off regime.
Surgical procedures for recordings under anesthesia
Implantation of microdialysis and silicone probes for recording under
ketamine/xylazine anesthesia rats was performed as described by David
et al. (2013) and Taylor et al. (2014). In brief, the initial dose of anesthet-
ics (ketamine, 120 mg/kg; xylazine, 20 mg/kg) and the maintenance dose
(ketamine, 42 mg  kg 1  h 1; xylazine 7 mg  kg 1  h 1) were injected
intraperitoneally. Body temperature was maintained at 37°C with a heat-
ing pad and measured with a rectal probe. A microdialysis probe (CMA
12 Elite), with 2 mm dialysis membrane length, was slowly (500 m every
5 min) inserted unilaterally into the VB thalamus (AP, 3.2 mm; ML, 5.3
mm; DV, 7 mm; Paxinos and Watson, 2007) at a 16° angle with respect
to the vertical axis such that its final position would rest between 0.05 and
1 mm away from the tip of the silicone probe, which was subsequently
inserted. Artificial CSF (ACSF) alone or containing ZD7288 (500 M in
the inlet tube) was then delivered through the dialysis at a constant flow
rate of 1 l per minute. A 32-channel silicone probe with four shanks
(Buzsaki32L-CM32, NeuroNexus Technologies) was then slowly low-
ered into the VB (AP, 3.2 mm; ML, 2.8 mm; DV, 4.5 mm), and the
full-band signal including unit activity was recorded during 40 min of
ACSF and 1 h of ZD7288 reverse microdialysis injection.
Surgical procedures for EEG recordings in freely moving rats
Rats under isoflurane anesthesia were implanted bilaterally with guide
cannulas for microdialysis probes so that their tips rested just above the
VB (AP, 3.2 mm; ML, 2.8 mm; DV, 4.5 mm). Frontal (AP, 2.0
mm; ML, 2.0 mm) and parietal (AP, 1.8 mm; ML,  5.0 mm) EEG
screws were then implanted, and the rats were allowed to recover for at
least 5 d. Twenty-four hours before each experiment, microdialysis
probes with 2 mm dialysis membrane were inserted into the VB guide
cannulas. On the day of recording, the rat was connected to the recording
apparatus to habituate to the recording cage for 1 h. While habituating,
ACSF was delivered via the inlet tube of the dialysis probes at 1 l/min to
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allow stabilization of the surrounding tissue. For GAERS, the recording
session consisted of 1 h of ACSF injection followed by 100 min of admin-
istration of either ACSF or ZD7288 (1–500 M in the inlet tube) solu-
tions, while recording the EEG continuously throughout the recording
session. For recording in GHB-injected rats, the 1 h habituation was
followed by a 40 min period where either ACSF or ZD7288 (500 M in the
inlet tube) solutions were delivered through the inlet tubing. Then, either
saline or -butyrolactone (GBL), a GHB pro-drug, was injected intraperito-
neally (100 mg/kg), and the EEG was recorded for 1 h. Rats and mice were
randomly assigned to receive either ACSF or ZD7288 first, followed by the
other solution a week later. No animal was treated more than twice.
Neuronal recordings in freely moving rats
When microdialysis was combined with unit recordings in freely moving
conditions, procedures similar to those described by Taylor et al. (2014)
were used. First, one guide cannula was implanted with the silicone probe
mounted on a microdrive and its tip placed above the VB. On the day of
the experiment, the dialysis probe delivering ACSF was inserted into the
guide cannula, and the microdrive was advanced until suitable thalamic
units were found. A control period of 20 min was always allotted before
delivering ZD7288 (500 M in the inlet dialysis tube). Note that unless
otherwise indicated, the concentration of ZD7288 is always expressed in
the test and figures as that of the solution perfused in the dialysis inlet
tube. The corresponding tissue concentration can be deduced consider-
ing the general dialysis recovery of 5–10% (Chan and Chan, 1999; David
et al., 2013; Montandon and Horner, 2013).
HCN-targeting and nontargeting shRNA
The shRNA design is similar to that in our previously published papers
(Chávez et al., 2014; Neuner et al., 2015). In brief, the HCN-targeting
shRNA sequence (CAGGAGAAGTACAAGCAAGTAGA) was chosen to
target a conserved region within the open reading frame of mouse and
rat HCN1– 4. A nontargeting shRNA (GAGGATCAAATTGATAGTAA
ACC), which showed no homology to any known genes, was used as a
control. Both sequences were screened for sequence homology to other
genes with NCBI-BLAST (www.ncbi.nlm.nih.gov/BLAST) and did not
contain known immune response-inducing motifs (GTCCTTCAA, CT
GAATT, TGTGT, GTTGTGT; Hornung et al., 2005; Judge et al., 2005;
Robbins et al., 2009). In addition, both sequences follow rational designs
developed for siRNAs (Amarzguioui and Prydz, 2004; Hsieh et al., 2004;
Reynolds et al., 2004; Takasaki et al., 2004; Ui-Tei et al., 2004; Huesken et
al., 2005; Vert et al., 2006; Ichihara et al., 2007; Katoh and Suzuki, 2007).
Desalted shRNA oligos containing a modified miR155 loop (GTTTTG
GCCACTGACTGAC) and overhangs complementary to BamHI and
XhoI restriction sites were custom synthesized (Invitrogen), resuspended
using Duplex Buffer (Integrated DNA Technologies), and cloned into a
“CreOff” adeno-associated virus (AAV) vector with a floxed cassette that
contains a U6 polymerase III promoter to drive shRNA expression and a
CMV promoter to drive eGFP expression for identification of transduced
neurons. Constructs were cloned into pFB-AAV shuttle plasmids to al-
low for a baculovirus expression system-based AAV production. AAV
constructs were maintained and propagated with Stbl3-competent cells
(Invitrogen). Strict attention was paid to the integrity of the vector-
inverted terminal repeats in plasmid preparations. All AAV plasmids
were verified by diagnostic enzyme digestions. High-titer AAVs with
serotype 9 were commercially produced by Virovek and included the
green fluorescent protein eGFP under a CMV promoter (Chávez et al.,
2014; Neuner et al., 2015) to label infected cells (see Fig. 7A).
Viral injection
Eighteen Stargazer mice were implanted with epidural fronto-parietal
stainless steel EEG screws under isoflurane anesthesia, as described pre-
viously for rats. A craniotomy was performed above the VB (AP, 1.8
mm; ML, 1.5 mm; Paxinos and Watson, 2007), and an A10_l Gastight
Hamilton syringe with a 34 GA needle that was filled with mineral oil and
viral vector (see below) was inserted vertically. Needles were then low-
ered slowly into the thalamus (DV, 3.0 mm from the pia) and left in
place for 10 min. The viral vector was diluted to a final titer of 2.18  10 13
vg (viral genome copy)/ml (control, nontargeting, shRNA) and 1.145 
10 13 vg/ml (HCN-shRNA), injected bilaterally (2  500 nl) at a rate of
100 nl/min using a programmable micro-pump (UMP3–1; WPI), and
allowed to disperse for an additional 10 min before the needle was slowly
retracted.
Normal (3-month-old) male C57BL/6J mice were given injections of
HCN-targeting (n  6) and nontargeting (n  7) shRNA (as described
above) into the VB for investigating the effect of these shRNAs on the
in vitro electrophysiological properties of TC neurons. Since the results
from these normal mice were similar to those obtained from Stargazer
mice, the electrophysiological data from the two strains were pooled.
Thalamic slice preparation, in vitro whole-cell recording, and
data analysis
Thirty-two to thirty-six days after the viral injection, a modified method
optimized for adult mice was used to prepare thalamic slices containing
the VB (Ting et al., 2014). Briefly, mice were deeply anesthetized with
ketamine/xylazine (80/8 mg/kg) and transcardially perfused with 20 –25
ml of cold (4°C) ACSF containing (in mM) 93 N-methyl-D-glucamine,
2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 5 N-acetyl-
L-cysteine, 5 Na-ascorbate, 3 Na-pyruvate, 10 MgSO4, and 0.5 CaCl2. The
brains were then quickly removed from the skull, blocked, and sliced
(320 m thickness) in the coronal plane. After a short (12 min) recovery
in a warmed (35°C) N-methyl-D-Glucamin ACSF, the slices were in-
cubated at room temperature (20°C) in HEPES-holding ACSF contain-
ing (in mM) 30 NaCl, 2.5 KCl, 1.2 NaH2PO4, 1.3 NaHCO3, 20 HEPES, 25
glucose, 5 N-acetyl-L-cysteine, 5 Na-ascorbate, 3 Na-pyruvate, 3 CaCl2,
and 1.5 MgSO4. For recording, slices were submerged in a chamber per-
fused with a warmed (35°C) continuously oxygenated (95% O2, 5%
CO2) ACSF containing (in mM) 130 NaCl, 3.5 KCl, 1 KH2PO4, 24
NaHCO3, 1.5 MgSO4, 3 CaCl2, and 10 glucose.
Whole-cell patch-clamp recordings of TC neurons located in the VB
were performed using an EPC9 amplifier (Heka Elektronik). Patch pi-
pettes (tip resistance, 4 –5 M) were filled with an internal solution
containing the following (in mM): 126 K-gluconate, 4 KCl, 4 ATP-Mg,
0.3 GTP-Na2, 10 HEPES, 10 kreatin-phosphate, and 8 biocytin, pH 7.25;
osmolarity, 275 mOsm. The liquid junction potential (13 mV) was
corrected off-line. Access and series resistances were constantly moni-
tored, and data from neurons with a 20% change from the initial value
were discarded. The ratio of the input resistance at the peak (Rpeak) and
that at the end of the 1-s-long voltage step (Rss; as illustrated in Fig. 5) was
taken as a measurement of the depolarizing “sag” elicited by HCN chan-
nel activation. Action potential amplitude was measured from threshold
(20 mV/ms on the first derivative of the membrane potential) to the peak
of the action potential. Analysis of these whole-cell data was performed
using custom routines written in Igor.
In vivo data acquisition and analysis
Spike sorting. For unit recordings, signals were digitized with a 64-channel inte-
grated recording system (version 2.3.0, 2006; Plexon) at 20 kHz with
16-bit resolution. EEG data were low-pass filtered with a windowed sinc
filter at 100 Hz and downsampled to 200 Hz. Spike sorting and data
preprocessing were performed with the Klusters, Neuroscope, NDMa-
nager, and Klustakwik software suites (Harris et al., 2000; Hazan et al.,
2006). A typical high-frequency burst of action potentials of TC neurons
was defined as a group of spikes that was separated by 	7 ms, was pre-
ceded by a 100 ms period of electrical silence, and showed the character-
istic decelerando pattern within a burst (Domich et al., 1986).
Spike-and-wave discharge analysis. The EEG was recorded using an
SBA4-v6 BioAmp amplifier (SuperTech), digitized at 1 kHz (Micro3
D.130; Cambridge Electronic Design) and analyzed with CED Spike2
version 7.3 and Matlab (R2011b; MathWorks). SWDs that accompanied
behavioral ASs were detected semiautomatically with the aid of the Sei-
zureDetect script (kindly provided by Dr. Steven Clifford, Cambridge
Electronic Design) in Spike2 version 7.3 as described in detail by Venzi et
al. (2016). For analysis of GAERS SWDs, data were normalized in two
steps: first, all values were measured as percentage variation compared
with the average values of the control periods, then all individual per-
centage values were recalculated as percentage change compared with the
average value at each time point of the control group (set to 0% change).
Only the second step of this calculation was applied to the SWDs of GHB
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and Stargazer data for which no control period exists. The time-frequency
representation of SWDs was performed with a wavelet transform of
SWD, as described by David et al. (2013). The frequency of SWDs was
estimated from the distribution of the intervals that separate each spike-
and-wave complex (SWC) extracted with the SeizureDetect program
(Cambridge Electronic Design).
Histology
To examine the relative position of the tracks of the microdialysis and
silicone probes, methods similar to those described by David et al. (2013)
and Taylor et al. (2014) were used. Data were excluded from analysis if
either the dialysis or the silicone probes were misplaced.
For HCN2 immunohistochemistry, brains were perfused with 4% PFA
and stored in 0.1 M PB with 0.05% sodium azide at 4°C before slicing at
40 m on a Vibratome (VT1000S; Leica Microsystems). After 1 h in 5%
normal horse serum blocking solution, the sections were incubated in
primary antibody rabbit anti-HCN2 (1:200; Alomone Labs) and diluted
in 0.1 M Tris-buffered saline (pH 7.4)/0.1% Triton X-100 (Sigma) and
3% Normal Goat Serum, followed by secondary antibody Cy3 donkey
anti-rabbit (1:500; Jackson ImmunoResearch Laboratories) and DAPI
staining (1:200; Millipore), and mounted in Vectashield (Vector Labo-
ratories) before imaging with a confocal microscope (FW 1000; Olym-
pus). Quantitative analysis of HCN and GFP expression levels were
performed with ImageJ software. Zones of interest of neuronal cell bod-
ies were delimited manually, and the intensity was measured in the re-
spective spectra (green,   594 nm for HCN; red,   488 nm for GFP).
GFP green fluorescence intensity (in arbitrary units) was taken as an
indicator of viral infection in a cell and correlated with the anti-HCN
antibody red fluorescence intensity (see Fig. 6D).
Experimental design and statistical analysis
Experiments with reverse microdialysis on thalamocortical unit activity
(Figs. 1, 2) were designed so that at least five neurons could be recorded
per data point (David et al., 2013; McCafferty et al., 2018). Experiments
involving SWD measurement involved a minimum of 6 –11 animals,
which in previous similar studies allowed statistical significance to be
detected (Cope et al., 2009). Immunohistological procedures were per-
formed on three animals per treatment group to collect enough thalamic
slices (Cope et al., 2009).
Group comparisons were performed using the Wilcoxon signed rank
test, and the Wilcoxon rank-sum test was used for paired or unpaired
datasets. A logistic regression of the dose-dependent effect of ZD7288 on
GAERS SWDs was performed with SigmaPlot. Linear regressions were
performed for correlating the HCN-related fluorescence intensity to the
GFP-related fluorescence intensity. Circular statistics was performed
using the Kuiper two-sample test. All quantitative data in the text and
figures are expressed as mean  SEM. Values were defined as outliers if
they were larger than q3  w(q3  q1) or smaller than q1  w(q3  q1),
where q1 and q3 are the 25th and 75th percentiles, respectively, and w is
1.5, which corresponds to 2.7 SDs for normally distributed data (as
defined in Matlab; Mathworks).
Results
Time course and diffusion of microdialysis-applied ZD7288
We first characterized the time course and diffusion of the Ih
antagonist ZD7288 applied via reverse microdialysis into the cen-
ter of the VB, the thalamic nucleus somatotopic with the cortical
“initiation site” of ASs in genetic rat models (Meeren et al., 2002;
Polack et al., 2007). To this end, we measured the firing rate of TC
neurons (the only neuronal population present in this thalamic
nucleus) using a silicone probe closely positioned to a dialysis
probe in ketamine/xylazine anesthetized Wistar rats (n  21; Fig.
1A). Under this condition, the EEG mostly expressed sleep slow
waves and TC neurons preferentially fired high-frequency bursts
Figure 1. Temporal and spatial dynamics of the effect of ZD7288 applied by reverse microdialysis in the VB of ketamine/xylazine-anesthetized Wistar rats. A, Position of the unilateral four-shank
silicone probe (4 thin orange lines) and microdialysis probe (black thick oblique line) on a rat brain schematic drawing at the level of the VB [modified from Paxinos and Watson (2007)]. The red
circled, striped area indicates the diffusion of ZD7288 as measured in D. B, Extracellular high-pass filtered traces from five adjacent contact points of a silicone probe show high-frequency bursts of
action potentials of three clustered (color-coded) TC neurons during ACSF (left) and ZD7288 (right) microdialysis application. Right, Enlargement of bursts from the same TC neuron before (top) and
during (bottom) ZD7288 (ZD) dialysis. The same y-scale is shown for all traces. C, Time course of total firing of TC neurons during ACSF (black) and ZD7288 (green) microdialysis injection (500 M in
the inlet tube). Data are shown as percentage firing relative to that during ACSF (solid lines and shadows, mean  SEM). The red vertical line (at time 0) indicates the start of ZD7288 application.
Data from 87 and 45 neurons for ACSF and ZD7288, respectively, from 21 Wistar rats are shown (see Materials and Methods for further details). D, Distance profile of the ZD7288 effect (green) on total
firing compared with ACSF (black; same number of neurons as in C). Horizontal bars indicate electrode position SDs relative to the dialysis membrane and calculated in 250 m space bins, and vertical
bars indicate SEM of ZD7288 effect. E, ZD7288-elicited increase in the number of spikes per burst (n  45 neurons; solid line and shadows, mean  SEM). Time is centered on the half-time of the
effect of ZD7288 estimated by a logistic function fit on the total firing rate variation after ZD7288 application. The box plot indicates median (red), upper and lower quartiles (box edges), extreme
points (whiskers), and outliers (red crosses; see Material and Methods, Experimental design and statistical analysis). Median postdrug (3.75 spikes/burst) is significantly higher than predrug (3.02
spikes/burst; *p  6.9 10 5, Wilcoxon signed rank test.).
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of action potentials (Fig. 1B). Unilateral application of 500 M
ZD7288 in the inlet dialysis tube, corresponding to a tissue con-
centration of 25–50 M for a standard dialysis recovery of 5–10%
(Chan and Chan, 1999; David et al., 2013; Montandon and
Horner, 2013), led to a maximum and sustained firing reduction
of 
50% within 40 min from the start of the injection (Fig. 1C).
This action was apparent in neurons located 	600 m from the
dialysis probe but was absent in those located 600 m away
from the dialysis probe (Fig. 1D). As it has been previously re-
ported in anesthetized rats during ZD7288 iontophoretic appli-
cation (Budde et al., 2005), bursts recorded in the continuing
presence of dialysis-applied ZD7288 were characterized by a sig-
nificantly increased number of action potentials (p  6.9.105,
n  45 neurons; Fig. 1E). Thus, in view of the dimensions of the
rat VB thalamic nucleus (Paxinos and Watson, 2007), ZD7288
applied via a microdialysis probe placed in the middle of the VB is
able to affect TC neuron firing in almost the entirety of this tha-
lamic nucleus (Fig. 1A, red circled, striped area) and mostly spar-
ing the nucleus reticularis thalamus (NRT), as we reported
previously for a similarly applied Ca 2 channel blocker (David et
al., 2013; Taylor et al., 2014).
Neuronal effects of microdialysis-applied ZD7288 during ASs
and interictal periods
No study so far has investigated the effect of Ih on TC neuron firing
under natural conditions (i.e., in nonanesthetized animals), proba-
bly because of technical difficulties. Thus, having established the
time course and diffusion of ZD7288, we then applied this antag-
onist by unilateral microdialysis into the VB while simultane-
ously recording firing activity of single TC neurons in a freely
moving AS model, the GAERS (n  3), with a close-by positioned
silicone probe (Fig. 2A,B). In contrast with the increase observed
in the same neuronal type in vitro (Lüthi et al., 1998), analysis of
the activity of TC neurons (n  7) showed that ZD7288 signifi-
cantly decreased the total firing by 
60 and 40% interictally and
ictally, respectively (Fig. 2C). When different types of firing were
analyzed individually, tonic firing was significantly reduced both
ictally and interictally by ZD7288 (Fig. 2D), whereas burst firing
was not (Fig. 2E). Importantly, in contrast to the results obtained
under anesthesia (Fig. 1E), the number of spikes per burst in TC
neurons recorded in freely moving rats was not significantly af-
fected by ZD7288 (Fig. 2F). Finally, the time distribution of the
extracellularly recorded action potentials with respect to the
SWC (analyzed with circular statistics) was different between
SWDs recorded during ACSF application andthoseduringZD7288
Figure 2. Effect of ZD7288 microdialysis injection in the VB on TC neuron firing in freely
moving GAERS. A, Position of the unilateral four-shank silicone probe (4 thin orange lines) and
microdialysis probe (black thick oblique line) on a rat brain schematic drawing at the level of the
VB [modified from Paxinos and Watson (2007)]. The red circled, striped area indicates the
diffusion of ZD7288 as measured in Figure 1D. B, Extracellular low-pass filtered traces from
the silicone probe show ictal periods (with SWDs) and interictal periods, with below raster of
clustered (color-coded) spikes of three TC neurons during ACSF (top traces) and ZD7288 (bottom
traces) application. Note the drastic change of firing between ictal and interictal periods.
4
C, D, Time course of total (C) and tonic (D) firing (solid line and shadows, mean  SEM) during
interictal periods (left) and during ASs (right) recorded during ACSF (data to the left of red
horizontal line) and ZD7288 (data to the right of the red horizontal line) microdialysis applica-
tion. Red vertical lines (at time 0) indicate the start of ZD7288 injection. The change in activity is
illustrated by the inset plots that show total and tonic firing rate (hertz) for individual neurons
during ACSF (predrug) versus ZD7288 (postdrug; with the black dashed line indicating equal
predrug and postdrug values; *significant p values from left to right are 0.016, 0.039, 0.023, and
0.016, Wilcoxon signed rank test; n  7 neurons). E, F, Plots, as inset plots in C and D, showing
the nonsignificant (n.s.) changes in burst firing and number of spikes per burst induced by
ZD7288 microdialysis during interictal and ictal periods ( p values from left to right are 0.078,
0.19, and 0.11, 0.5, Wilcoxon signed rank test; n  7 neurons). G, Left, Circular distribution plot
of action potentials with respect to the SWC indicates a significant different distribution before
(black line) and during (red line) ZD7288 application ( p  0.001, Kuiper 2-sample test; n 
58.8 10 3 vs n  40.6 10 3 action potentials). Right, The maximal difference in the time distri-
bution of action potentials between ACSF (black line, top plot) and ZD7288 (red line, top plot)
occurs just before 0° (defined as the peak of the SWC), as highlighted by the subtraction of these
two curves (gray line, bottom plot).
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injection (ACSF mean angle, 2.2°;
ZD7288 mean angle, 3.4°; p  0.001,
Kuiper test; Fig. 2G, left and top right
plots), with the maximal difference be-
tween these two experimental conditions
occurring just before 0° (Fig. 2G, bottom
right plot).
Pharmacological block of HCN
channels in VB TC neurons impairs the
expression of ASs
We next investigated the effect of blocking
Ih in VB TC neurons on spontaneous ge-
netically determined ASs in freely moving
GAERS (Fig. 3A). Application of ZD7288
by bilateral reverse microdialysis in the
VB produced a marked and concentration-
dependent (EC50  29 M) decrease in the
total time spent in seizures, with 500 M
almost abolishing ASs (82  3%, p 
4.104, n  6), whereas no significant ef-
fect was observed with 1 M (n  8; Fig.
3B,C). These effects were mostly driven
by a marked reduction (75  4%, p 
4.104) in the number of seizures (Fig.
3E), though a small decrease in the length
of individual seizures (34  13%, p 
0.025) was also observed (Fig. 3D).
Since genetically determined and phar-
macologically induced ASs may depend on
different cellular and network mechanisms
(Crunelli and Leresche, 2002; Blumenfeld,
2005), the action of ZD7288 was then in-
vestigated in ASs elicited by systemic in-
jection of a GHB prodrug, GBL (hereafter
referred to as GHB; Venzi et al., 2015), in
Wistar rats implanted with bilateral dialy-
sis probes in the VB (Fig. 4A). Well sepa-
rated ASs mainly occur up to 20 –30 min
after GBL administration (Fig. 4B; Venzi
et al., 2015). Therefore, GHB was injected
40 min after the start of 500 M ZD7288
microdialysis application, i.e., at a time
when the effect of ZD7288 throughout the
VB has reached steady state (compare Fig.
1C). As observed in GAERS, ZD7288
significantly decreased (58  9%, p 
9.4.104, n  11) the total time spent in
seizures in the first 20 min after GHB in-
jection (Fig. 4C). However, the ZD7288-
elicited reduction was smaller than that
observed in GAERS and was mainly at-
tributable to a reduction in the length of
individual seizures (40  7%, p  0.016;
Fig. 4D) with no statistically significant ef-
fect on the number of seizures (Fig. 4E).
No effect of ZD7288 on GHB-elicited ASs
was observed beyond 20 min after GHB
injection (data not shown). Thus, the phar-
macological block of Ih in VB TC neurons
by ZD7288 decreases both genetically deter-
Figure 3. Effect of bilateral microdialysis injection of ZD7288 in the VB on ASs in freely moving GAERS. A, Position of the bilateral
microdialysis probes (black thick lines) and diffusion areas (red circled, striped areas) of ZD7288 are depicted on a rat brain
schematic drawing at the level of the VB [modified from Paxinos and Watson (2007)]. B, Representative EEG traces showing
spontaneous SWDs during ACSF and ZD7288 (500 M in the inlet tube) microdialysis application. C, Time course (left) and
concentration–response curve (right) of ZD7288 effect (solid line and shadows, mean  SEM) on the total time spent in seizure
normalized to ACSF values (see Materials and Methods for further details). The illustrated concentration color code refers to the
ZD7288 concentration in the dialysis inlet tube. Time 0 indicates the start of ZD7288 dialysis. The number of animals is as follows:
9 (ACSF), 4 (1 M), 8 (10 M), 7 (100 M), 2 (250 M), and 6 (500 M) [left, *p 	 0.05, **p 	 0.01, p  0.023 (100 M), and p 
4.10 4 (500 M), Wilcoxon rank-sum test on averages between ACSF and 40 – 80 min data from the start of the ZD7288
application]. Absolute ACSF values (mean  SEM) for the six reported time points are 295.4  51.6, 308.8  54.5, 276.7  53.8,
275.2  48.0, 219.1  45.5, and 246.3  52.5 s. A logistic fit of the concentration–response curve of ZD7288 indicate an EC50 of
29 M. D, Same as C for the length of individual seizures. Absolute ACSF values (mean  SEM) are 7.91  1.29, 7.64  1.33,
8.241.28, 7.961.33, 7.291.25, and 6.130.83 s (left, *p 0.025, Wilcoxon rank-sum test). E, Same as C for the number
of seizures. Absolute ACSF values (mean  SEM) are 56.9  10.4, 46.9  8.6, 43.4  9.1, 51.0  11.7, 43.9  11.2, and 45.6 
10.3 seizures (left, *p  0.011, **p  4.10 4, Wilcoxon rank-sum test).
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mined and pharmacologically elicited ASs in freely moving animal
models.
Cellular effects of the HCN-targeting shRNA
In addition to the pharmacological block, we investigated whether
reducing the expression of HCN channels in the VB using shRNA
could also suppress ASs. First, we assessed the functional effect of
this genetic approach by monitoring the
electrophysiological properties of VB TC
neurons in slices taken from mice previ-
ously (32–36 d) given injections of either
HCN-targeting or nontargeting shRNA in
this thalamic nucleus (see Materials and
Methods). Only TC neurons that showed
eGFP fluorescence were patch clamped in
slices from HCN-targeting shRNA mice.
The resting membrane potential of TC
neurons in slices from animals given in-
jections of HCN shRNA (68  6 mV,
n  18) was more hyperpolarized than in
mice that had received the nontargeting
shRNA (63  7 mV, n  18, p  0.032;
Fig. 5D). Moreover, the depolarizing sag
of hyperpolarizing voltage steps was
almost abolished in VB TC neurons
infected with HCN-targeting shRNA
compared with nontargeting shRNA (Fig.
5A,B), resulting in a similar input resis-
tance at steady state (Rin-ss) in the two
groups (217  75 M, n  18, and 186 
73 M, n  24, respectively; p  0.56; Fig.
5F). Moreover, the steady-state and peak
input resistance ratio (Rin-ss/Rin-peak)
was significantly larger in neurons from
HCN-targeting than nontargeting shRNA
(0.94  0.08 and 0.82  0.01, n  18 and
24, respectively; p  6.2.105; Fig. 5E),
indicating that the sag difference is not a
consequence of a difference in Rin. Appli-
cation of ZD7288 (10 M) to five TC neu-
rons transfected with HCN-targeting
shRNA abolished the small remaining sag
(where present) but had no effect on the
resting membrane potential (not shown).
In contrast, action potential properties
were not affected (threshold, 45  6 vs
48  5 mV; amplitude, 82  2 mV vs
80  2 mV; both n  15 and p  0.17 and
p  0.46, respectively; Fig. 5G,H). These
data demonstrate that our HCN-targeting
shRNA does selectively affect Ih-depen-
dent membrane properties of VB TC
neurons without altering other neuro-
nal properties.
Genetic ablation of HCN channels
reduces ASs
Having established the functional effect of
the HCN-targeting shRNA on TC neuron
membrane properties, we next assessed
the effect of this genetic suppression of Ih
on ASs in nine Stargazer mice, a mono-
genic mouse model of ASs (Fletcher and
Frankel, 1999), which had received bilateral injection of viral
construct into the VB. Another group (n  9) of Stargazer mice
received bilateral injections of a nontargeting shRNA. ASs were
then monitored every 4 d for over 1 month. A statistically signif-
icant reduction in the total time spent in seizures (57  12 and
45  9%, p  0.036 and p  0.029, n  9) and the average length
of individual seizures (38  7 and 31  6%, both p  0.035 and
Figure 4. Effect of bilateral microdialysis administration of ZD7288 in the VB on GHB-elicited ASs in freely moving Wistar rats.
A, Position of the bilateral microdialysis probes (black thick lines) and diffusion areas of ZD7288 (red circled, striped area) are
depicted on a rat brain schematic drawing at the level of the VB [modified from Paxinos and Watson (2007)]. B, Representative EEG
traces showing GHB-elicited SWDs during ACSF and ZD7288 (500 M in the inlet tube) administration. C, Left, Effect (meanSEM)
of ZD7288 (500 M, filled bars, n  11 rats) versus ACSF (open bars, n  7) on total time spent in seizures illustrated for 10 min
bins. ZD7288 dialysis started 40 min before GHB injection (see Materials and Methods for further details). Right, Individual data
points (open, ACSF; filled, ZD7288) for the 0 –10 and 10 –20 min time bins after GHB injection are normalized to data recorded
during ACSF injection (**p  9.4 10 4, *p  0.013, Wilcoxon rank-sum test, n  7 and 11 animals in each group). D, E, Similar bar
graphs (left) and scatter plots (right) as in C for average length of individual seizures (D; *p  0.016, **p  0.0082, Wilcoxon
rank-sum test, n  7 and 11 animals in each group) and number of seizures (E; p  0.1, p  0.34, Wilcoxon rank-sum test, n 
7 and 11 animals in each group).
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p  0.043) was observed in HCN-targeting compared with non-
targeting shRNA-injected mice at 28 and 32 d after injection,
respectively (Fig. 6A–C). The reduction in the average number of
seizures was not significant at both days (35  14 and 8  12%,
respectively, p  0.056 and p  0.42; Fig. 6D).
At the end of the behavioral experiment (i.e., day 32 after
injection), the brain of the Stargazer and wild-type mice, which
had been injected, were harvested to measure GFP and HCN
expression in thalamic and cortical slices (Fig. 7B). Triple labeling
of VB TC neurons showed the colocalization of GFP, HCN2, and
DAPI in all mice (Fig. 7C). As shown in Figure 7, C and D, in
HCN shRNA-infected mice, TC neurons that were immunopo-
sitive for GFP had a low HCN immunoreactivity compared with
nontargeting shRNA-infected animals. Indeed, a negative corre-
lation was observed between HCN and GFP immunostaining in
five of the six slices that had received the HCN shRNA (Fig. 7D,
bottom), whereas no correlation was observed in all six mice that
received injections of the missense RNA (Fig. 7D, top; linear
regression R 2  0.12, p  3.82.109 vs R 2  0.0004, p  0.77
when pooling all data points together). Notably, the expression of
the virus was restricted to the VB, as indicated by the data show-
ing that (1) the GFP expression remained restricted to the thala-
mus and only projecting fibers were visible in the neocortex (Fig.
7B,C) and (2) cortical expression of HCN immunofluorescence
was still prominent in the neocortex (Fig. 7C, bottom).
Effect of thalamic Ih block on SWD parameters
Finally, we compared some SWD parameters between control
animals and those with a pharmacological or genetic suppression
of thalamic HCN channel function. The time-frequency repre-
sentation of SWDs indicated a decrease in the first harmonic
(
14 Hz) in the presence of ZD7288 in GAERS (Fig. 8A). To
quantify this change, we calculated the averaged power spectra
and found that the main frequency component of the SWDs at 7
Hz had a significantly increased power whereas the harmonic at

14 Hz was significantly smaller during the seizures that remained
in the presence of ZD7288 in GAERS (Wilcoxon rank-sum test;
control, n  142; ZD7288, n  45 seizures; p  2.4.106; not shown).
However, these changes were not observed after suppression of
HCN channels with ZD7288 during GHB-elicited seizures and
with shRNA in Stargazer mice. Moreover, the frequency of SWDs
(estimated from the peak of interSWC-spike probability density;
Fig. 8B–D, left) was not significantly different between control
conditions and during the block of thalamic Ih for both sponta-
Figure 5. Effect of the HCN-targeting shRNA on the membrane properties of VB TC neurons in vitro. A, Representative voltage responses of VB TC neurons to a hyperpolarizing and depolarizing
current step (100 and 50 pA, respectively) from nontargeting (black traces, control) and HCN-targeting shRNA-injected (red traces, shRNA) mice (membrane potential, 60 mV for both).
Triangles and squares indicate the time of measurement of peak and steady-state input resistance (Rin-peak and Rin-ss, respectively, in the other panels). Note the lack of a depolarizing sag in the
hyperpolarizing response of the HCN-targeting shRNA-injected neuron. B, Averaged hyperpolarizing voltage responses (solid line, mean; shadow, SEM) in all recorded neurons show the marked
reduction in the depolarizing sag in neurons injected with HCN-targeting shRNA (n  18) compared with control (n  18). C, Voltage– current plots from all neurons show the lack of inward
rectification in HCN-targeting shRNA-injected mice (triangles and squares indicate amplitude of hyperpolarizing pulse at peak and steady state, respectively, compare A, B). D–H, Resting membrane
potential (D), ratio of Rin-ss and Rin-peak (E), Rin-ss (F), and action potential (AP) threshold (G) and amplitude (H) for neurons treated with nontargeting (black squares, control) and HCN-targeting
shRNA (red squares, shRNA; large symbols indicate mean  SEM; * and ** indicate statistical significance; n.s., not significant; p values are 0.032 (D), 6.2 10 5 (E), 0.56 (F), 0.17 (G), and 0.44 (H);
Wilcoxon rank-sum test).
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neous ASs in GAERS (control, 7.0  0.1
Hz, n  9; ZD7288, 6.8  0.1 Hz, n  6;
p  0.11) and in Stargazer mice (control,
6.4  0.2 Hz, n  7; shRNA, 6.1  0.2 Hz,
n  8; p  0.44; Fig. 8 B,D, right) as well
as for GHB-elicited ASs (control, 6.8 
0.5 Hz, n  6; ZD7288, 7.0  0.5 Hz, n 
8; p  0.82; Fig. 8C, right).
Discussion
This study provides the first demonstra-
tion that (1) a reduction in Ih function in
TC neurons of three animal models of ab-
sence epilepsy does reduce ASs and (2) the
overall effect of blocking TC neuron HCN
channels is a marked reduction in their
firing rate both ictally and interictally.
Therefore, in contrast to previous in vitro
investigations and in vivo studies under
anesthetic/neuroleptic regimes (Kuisle et
al., 2006; Kanyshkova et al., 2012; Cain et
al., 2015), these results demonstrate that
Ih of TC neurons positively modulates the
expression of ASs and support the view
that the increased HCN channel function
reported in TC neurons of genetic absence
epilepsy models does contribute to and/or
aggravate ASs and is not simply a seizure-
related compensatory mechanism.
Action of ZD7288 in freely
moving animals
Before discussing the implications of our
findings for ASs, it is important to con-
sider some issues related to ZD7288 ac-
tion. First, since ZD7288 concentration in
the neuronal tissue is approximately one
order of magnitude smaller than that in
the inlet tube of the microdialysis probe
(Chan and Chan, 1999), we are confident
that the tissue concentrations achieved in
our study are similar to those reported by
us and others as selective for Ih (Harris
and Constanti, 1995; Hughes et al., 1998;
Blethyn et al., 2006). Indeed, we observed
a significant effect on ASs at ZD7288 tis-
sue concentrations as low as 10 M. More-
over, the sigmoid shape of the ZD7288
concentration–response curve on GAERS
ASs (Fig. 3C) speaks against an action on
Figure 6. Effect of bilateral injection in the VB of an HCN shRNA on ASs in freely moving Stargazer mice. A, Representative EEG
traces showing spontaneous SWDs in a nontargeting control shRNA (top) and an HCN shRNA-injected Stargazer mouse (bottom).
B–D, Left, Effect of shRNA injection (solid line and shadows, meanSEM; red line, n9) on total time spent in seizure (B), length
4
of individual seizures (C), and number of seizures (D) com-
pared with nontargeting control shRNA (black line, n  9)
measured at the indicated days after shRNA injection (day 0).
Values are normalized to control group mean (black line) for
each time point. Right, Histograms of absolute values of total
time, length of individual seizures, and number of seizures for
test days 28 and 32 (3 h recordings; * indicates statistical sig-
nificance; p values are 0.036 and 0.029 (A), 0.035and 0.043
(B), and 0.056 and 0.42 (C; Wilcoxon rank-sum test). Absolute
values for the control group in all other test days were not
different from those of days 28 and 32.
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two different cellular targets under the freely moving conditions
of this study. Indeed, in view of the standard 5–10% recovery rate
of dialysis membranes, the EC50 (29 M) of ZD7288 found here in
vivo on the total time spent in seizures is similar to the 2 M EC50
observed in vitro on Ih (Harris and Constanti, 1995). It is also
unlikely that ZD7288 effect on ASs is mediated by an unselective
action on Na channels since under the same microdialysis con-
ditions ZD7288 decreases tonic, but not burst, firing of TC neu-
rons in freely moving GAERS. Finally, the similarity in the effect
on ASs with either the shRNA-elicited or ZD7288-mediated
reduction of HCN channels in Stargazer or GAERS and GHB
models, respectively, indicates that ZD7288 action under our ex-
perimental freely moving conditions is selective for Ih.
Second, the ability of ZD7288 to affect GHB-elicited ASs only
in the first 20 min after GHB administration should not be sur-
prising since we recently showed that it is only in this initial
period after injection that GHB elicits well separated bona fide
ASs (with their clear behavioral and EEG components), whereas
subsequent activity is characterized by a behavior more consis-
tent with sedation/hypnosis and is accompanied by continuous
low-frequency waves in the EEG (Venzi et al., 2015).
Third, a presynaptic, non-Ih-mediated action of ZD7288,
which is present at concentrations known to affect Ih, was re-
ported at hippocampal synapses (Chevaleyre and Castillo, 2002;
Mellor et al., 2002). However, this ZD7288 effect is absent at neu-
romuscular junctions (Beaumont and Zucker, 2000; Beaumont et
al., 2002) and has not been investigated at TC neuron synapses.
Moreover, all the above data were obtained in vitro, and thus it is
not known whether this presynaptic, non-Ih-mediated action of
ZD7288 occurs in vivo in freely moving animals (as those used in
Figure 7. Genetic suppression of thalamic HCN channels decreases their expression in VB. A, AAV construct includes eGFP and shRNA targeting HCN subunits or nontargeting HCN subunits.
B, Composite image showing GFP fluorescence restricted to thalamic nuclei and their projection to somatotopic cortical areas. Note barrels in somatosensory cortex. C, Top row, Confocal images
showing GFP and intrinsic HCN2 expression in DAPI-positive VB TC neurons from a Stargazer mouse that received injections of the nontargeting control shRNA. Middle row, Same for a mouse that
received injections of the shRNA targeting the HCN sequence. Note the low level (or absence) of HCN fluorescence in those TC neurons that express a high level of GFP signal (white arrowheads)
compared with cells expressing a low level of GFP (white arrows). Bottom row, Same for a cortical area of the same mouse. Note the absence of GFP-positive soma in the cortical section and the low
level of HCN signal in the thalamic section (scale bar, 10 m). D, Quantifications of GFP and HCN expression in thalamic sections of Stargazer mice that received the nontargeting control shRNA (top)
and the HCN targeting shRNA (bottom) for each neuron (symbols). Each line corresponds to the linear regression between the green (GFP) and the red (HCN) fluorescence of neurons from a single
section. The same color line or symbols indicate cells of the same section. None of the correlations for the nontargeting control shRNA was significant ( p  0.31, 0.14, 0.23, 0.67, 0.051, and 0.59),
whereas five of six sections from mice that received injections of the shRNA had a significant negative correlation ( p  0.041, 0.0006, 0.001, 0.03, 0.17, and 0.0001). Red dashed lines indicate the
linear regression for the entire population of neurons (top, p  0.77; bottom, p  3.82 10 9).
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the present study), a condition where because of the more depo-
larized membrane potential than in in vitro experiments the
voltage-dependent K current(s) that might underlie this ZD7288
effect (Chevaleyre and Castillo, 2002) may not be operative. In-
deed, the similarity of the action of ZD7288 and the HCN-
targeting shRNA support the view that the observed effect of
ZD7288 on genetically determined and pharmacologically in-
duced ASs occur via this drug action on Ih of TC neurons.
Ih modulation of TC neuron ictal firing
Microdialysis application of ZD7288 in the GAERS VB increased
the burst duration in TC neurons during ketamine/xylazine an-
esthesia, as shown previously in WAG/Rij rats under pentobarbi-
tal or neuroleptic regime (Budde et al., 2005). In contrast, in
freely moving GAERS, ZD7288 did not affect interictal and ictal
burst firing and burst duration, whereas total and tonic firing
were decreased both between and during ASs. This differential
action of ZD7288 on the two patterns of TC neuron firing is
intriguing: it may be that the removal of the depolarizing influ-
ence of Ih has little effect on burst firing as TC neurons are rela-
tively depolarized during ASs (Pinault et al., 1998), whereas it
easily affects tonic firing. Alternatively, the somatodendritic dis-
tribution of HCN channel subtypes in TC neurons (Abbas et al.,
2006) may contribute differently to the generation of tonic and
burst firing (Connelly et al., 2015, 2016). Finally, the increase in
tonic GABAA current that is present in TC neurons of the GAERS,
Stargazer, and GHB models (Cope et al., 2009) may differently
offset the action of a decreased Ih on the summation of ictal
corticothalamic EPSPs in these neurons (Ying et al., 2007), as it
has been shown in cortical pyramidal neurons (Chen et al., 2010).
The recent characterization of the firing dynamics of thalamic
neurons in freely moving GAERS and GHB models show that
during ASs single TC neurons are mostly electrically silent or fire
single action potentials, with T-type Ca2 channel-mediated bursts
of action potentials occurring rarely (McCafferty et al., 2018). More-
over, block of T-type Ca2 channels of TC neurons does not affect
behavioral ASs and the synchrony of the ictal thalamic output to
the neocortex (McCafferty et al., 2018). These data, together with
(1) the ZD7288-induced reduction of tonic but not burst firing
(Fig. 2) and (2) the block of behavioral ASs after the pharmaco-
logical or genetic suppression of TC neuron HCN channels (Figs.
3, 4, 6), suggest that the most likely role for HCN channels of TC
neurons in ASs is a contribution to the membrane potential: thus,
the block of HCN channels of TC neurons will hyperpolarize
these neurons, decreasing the synchronized thalamic output to
the neocortex, thus compromising the re-engagement of the cor-
tical network during ongoing seizures and ultimately being re-
sponsible for the reduction of ASs. Importantly, although the
hyperpolarization induced by the block of Ih may increase T-type
Ca 2 channel availability and thus the generation of a low-
threshold spike, as observed in thalamic slices and in the whole
animal under an anesthesia/neurolept regimen (Fig. 1; Budde et
al., 2005), burst firing itself does not increase during ictal activity
in the presence of ZD7288 in freely moving animals (Fig. 2),
probably because of the less negative membrane potential in the
latter than in the former vigilance state.
Opposite role for cortical and thalamic Ih in ASs
In the WAG/Rij and GAERS models, different, and at times con-
trasting, results have been reported on Ih of TC neurons (in either
VB or dorsolateral geniculate nucleus), including a clear increase
in amplitude (Cain et al., 2015), responsible for the reduced burst
firing, an increased channel density but a hyperpolarized V1/2
Figure 8. Effect of pharmacological and genetic suppression of Ih on SWD properties.
A, Representative examples of wavelet transform (top plots) of SWDs (bottom traces) before
(ACSF) and during ZD7288 application. A clear loss of power is visible toward the end of the SWD
recorded during ZD7288 application. A decrease in the first harmonic indicates a reduction of
the spike component and an increase in the wave component of the SWD. B–D, Frequency
analysis of SWDs in the GAERS (B; p  0.11, n  9, n  6) and GHB (C) models injected with
ZD7288 ( p  0.83, n  6, n  8) and in Stargazer mice treated with HCN-targeting shRNA
(D; p  0.44, n  8, n  7; left, probability density plots of intervals between spike of SWCs;
right, scatter plots of peak frequency for individual animals with mean  SEM; Wilcoxon rank-
sum test).
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(Kanyshkova et al., 2012), or no apparent alteration in amplitude
but an altered response to cAMP (Kuisle et al., 2006). The in-
creased Ih of GAERS TC neurons has been suggested to be re-
sponsible for the reduced burst firing in vitro (Cain et al., 2015).
In contrast, spontaneous or induced ablation of HCN2 channels
leads to ASs and an enhanced ability to generate burst firing in TC
neurons in vitro (Ludwig et al., 2003; Chung et al., 2009; Heuermann
et al., 2016).
Our present results provide direct evidence that a pharmaco-
logical or genetic block of HCN channels in TC neurons reduces
behavioral ASs in three freely moving absence epilepsy models.
Although all these data may appear controversial, their apparent
disagreement may originate from the “thalamocentric” interpre-
tation of in vivo data obtained from brain-wide genetic manipu-
lations that had explained these results on ASs by almost exclusive
effects on thalamic network activity discarding any contribution
by cortical HCN channels. Thus, in view of our results, it is more
likely that the pro-absence effect of global HCN2 knock-out in
normal mice (Ludwig et al., 2003) results from a cortical Ih loss of
function. Similarly, a developmental decrease of HCN1 (but not
HCN2) channels that leads to an Ih loss of function in the apical
dendrites of layers 5 pyramidal neurons has been reported in the
WAG/Rij absence model (Kole et al., 2007). In contrast, global
HCN1 knock-out mice do not show an absence phenotype (Chen
et al., 2009; Zhou et al., 2013), and Ih is increased in the soma of
GAERS cortical layer 5/6 neurons (Williams et al., 2016). Whether
these contradictory cortical data stems from compensatory changes
in knock-out mice or are simply a reflection of opposite changes in
cortical Ih in diverse models (Di Pasquale et al., 1997; Strauss et al.,
2004) remains to be investigated.
In conclusion, using a pharmacological and a genetic ap-
proach to selectively suppress HCN channel function in TC neu-
rons of three well established AS models, this study provides
conclusive evidence on the longstanding controversial role for
thalamic Ih in ASs by demonstrating that block of HCN channels
of TC neurons prevents absence seizures.
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